Emisphere Technologies, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Emisphere Technologies, Inc.
Fostering a Culture of Innovation, From Evolutionary To Revolutionary
Innovation is a key to long-term success for biopharma companies, but building the right climate to foster creative problem-solving is challenging. Questioning assumptions and constraining the target of innovation can propel a company forward.
TytoCare Plans To Integrate More AI Into Diagnostics To Drive Longitudinal ‘Family’ Care At Home
Medtech Insight recently sat down with TytoCare’s chief commercial officer Tamir Gotfried to discuss plans for driving virtual care in the home, and engage physicians and consumers, at a time when pandemic-era state-level telehealth flexibilities continue to evolve.
‘This Is The Way Of The Future’: Digital Health Experts Share Thoughts, Experiences With Generative AI
Panelists and health experts at the Digital Health 2023 conference offered views on how generative AI such as ChatGPT could shape the future of health care as well as use cases in their own organizations, from analyzing data for clinical trials to generating answers for patients, listening into calls, and augmenting physicians’ work.
Lessons In Leadership And Biotech Growth From Rallybio CEO Martin Mackay
Veteran pharma leader Martin Mackay, CEO of Rallybio, recently spoke with In Vivo about building a new company on the cusp of retirement, what drives him, how he leads and what he is excited about in the company’s pipeline.
- OTC, Consumer
- Large Molecule
- Other Names / Subsidiaries
- Clinical Technologies Associates, Inc.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.